Your browser doesn't support javascript.
loading
Highlights and recent developments in airway diseases in EAACI journals (2018).
Bousquet, Jean; Akdis, Cezmi A; Grattan, Clive; Eigenmann, Philippe A; Hoffmann-Sommergruber, Karin; Agache, Ioana; Jutel, Marek.
Afiliação
  • Bousquet J; Fondation partenariale FMC VIA-LR, MACVIA-France, Montpellier, France.
  • Akdis CA; INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France.
  • Grattan C; UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, France.
  • Eigenmann PA; EUFOREA, Brussels, Belgium.
  • Hoffmann-Sommergruber K; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Agache I; Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland.
  • Jutel M; St John's Institute of Dermatology, Guy's Hospital, London, UK.
Allergy ; 74(12): 2329-2341, 2019 12.
Article em En | MEDLINE | ID: mdl-31573676
ABSTRACT
The European Academy of Allergy and Clinical Immunology (EAACI) supports three journals Allergy, Pediatric Allergy and Immunology, and Clinical and Translational Allergy. EAACI's major goals include supporting the promotion of health, in which the prevention of allergy and asthma plays a critical role, and disseminating the knowledge of allergic disease to all stakeholders. In 2018, the remarkable progress in the identification of basic mechanisms of allergic and respiratory diseases as well as the translation of these findings into clinical practice were observed. Last year's highlights include publication of EAACI guidelines for allergen immunotherapy, many EAACI Position Papers covering important aspects for the specialty, better understanding of molecular and cellular mechanisms, identification of biomarkers for disease prediction and progress monitoring, novel prevention and intervention studies, elucidation of mechanisms of multimorbidities, introduction of new drugs to the clinics, recently completed phase three clinical studies, and publication of a large number of allergen immunotherapy studies and meta-analyses.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças Respiratórias Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Allergy Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças Respiratórias Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Allergy Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França